Lixte Biotechnology Holdings, Inc. Profile Avatar - Palmy Investing

Lixte Biotechnology Holdings, Inc.

Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on i…

Biotechnology
US, Pasadena [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Lixte Biotechnology Holdings, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of LIXT's Analysis
CIK: 1335105 CUSIP: 539319202 ISIN: US5393193017 LEI: - UEI: -
Secondary Listings
LIXT has no secondary listings inside our databases.